- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06488677
Influence of Social Determinants on Lifestyle Modification Adherence in People With Prediabetes
Influence of Social Determinants on Lifestyle Modification Adherence in People With Prediabetes: A Sequential Explanatory Mixed-Methods Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Type 2 diabetes (T2D) is a major risk factor for adult morbidity and mortality and represents a public health burden due to its rising global prevalence. T2D is preceded by prediabetes, a phase characterized by higher-than-normal blood glucose levels that do not reach the threshold required for a T2D diagnosis. It is estimated that 70% of people with prediabetes will eventually develop T2D, with a mean annual incidence rate ranging from 5% to 10%.
Importantly, socioeconomic status exacerbates the risk of developing chronic diseases such as T2D, as people from underprivileged social classes are significantly more susceptible to the development of the disease and its complications, when compared to the more privileged.
In fact, it has been observed that the risk of developing T2D extends beyond physiological factors. Social determinants (SD) such as age, gender, ethnicity, postal code, or socioeconomic status, and health beliefs are strong predictors of disease onset and progression. Populations with a low socioeconomic status (i.e., economically disadvantaged backgrounds, lower health literacy levels, lower educational status, and often, from ethnic and racial minorities), are known to experience reduced access to healthcare including health promotion programs. They also have lower adoption rates of health behaviors, such as physical activity (PA) and healthy diet, and thus be at increased risk of chronic diseases such as T2D, which finally increases their likelihood to suffer inequalities in mortality.
For all of the above, this study aims to explore the influence of SD on adherence behaviors in individuals with prediabetes included in the PREDIPHONE trial, using a mixed-methods sequential explanatory design. The findings from both the quantitative and qualitative phases will be integrated to offer a comprehensive understanding of the complex phenomenon of adherence.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Miquel Bennasar Veny, PhD
- Phone Number: +34 971172367
- Email: miquel.bennasar@uib.es
Study Contact Backup
- Name: Aina M Yanez Juan, PhD
- Phone Number: +34 971172367
- Email: aina.yanez@uib.es
Study Locations
-
-
Balearic Islands
-
Palma De Mallorca, Balearic Islands, Spain, 07122
- University of the Balearic Islands
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- participants of the PREDIPHONE trial assigned to the intervention group and who complete the 9-month intervention period
Exclusion Criteria:
- Participants from the control group or those who withdrew from the trial.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
High adherence
Participants with high adherence to the lifestyle intervention
|
Nurse-led telephone personalized dietary and PA advice
|
|
Low adherence
Participants with low adherence to the lifestyle intervention
|
Nurse-led telephone personalized dietary and PA advice
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to healthy lifestyle recommendations
Time Frame: at month 9 of the intervention period
|
Adherence to healthy lifestyle recommendations measured through a composite index generated with data from 1) dietary adherence assessed using the 14-item PREDIMED Mediterranean Diet questionnaire and 2) physical activity adherence evaluated using the REGICOR Abbreviated Questionnaire.
|
at month 9 of the intervention period
|
|
Facilitators and barriers to adherence to lifestyle changes
Time Frame: at month 9 of the intervention period
|
Facilitators and barriers to adherence to lifestyle changes such as social and family support, knowledge about one's health condition, health beliefs, and the patient-professional relationship
|
at month 9 of the intervention period
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023/02723
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PreDiabetes
-
Shifa International HospitalRecruitingPrediabetes | Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) | Prediabetes or DiabetesPakistan
-
Mayo ClinicRecruiting
-
Aga Khan UniversityLinnaeus University; Kenyatta UniversityRecruiting
-
Chonbuk National University HospitalCompletedPreDiabetes
-
National Yang Ming UniversityRecruiting
-
Albert Einstein College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Clinical Nutrition Research Centre, SingaporeSingapore Institute for Clinical SciencesCompleted
-
Northwestern UniversityAllianceChicago; Erie Family Health CentersCompleted
-
Ohio UniversityTouro University, CaliforniaCompletedPreDiabetes
Clinical Trials on Lifestyle changes (diet and physical activity)
-
National Institute of Diabetes and Digestive and...Completed
-
University Hospital, GrenobleRecruitingLifestyle Risk Reduction | Inactivity, PhysicalFrance
-
University College of AntwerpUnknownObesity | OverweightBelgium
-
University of OsloThe Research Council of Norway; European CommissionCompletedMetabolic Syndrome | Type 2 DiabetesNorway
-
Tel-Aviv Sourasky Medical CenterKaMaH - The Center for Health-Promoting TherapiesRecruitingIndolent LymphomaIsrael
-
University of Roma La SapienzaCompletedChanges in the Hypotalamic-pituitary Region of Patients With Metabolic Syndrome and Obesity (CHIASM)Metabolic Syndrome | Overweight and ObesityItaly
-
University of California, DavisCompletedOverweight and ObesityUnited States
-
University of California, DavisNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Universidad de ZaragozaCompleted
-
University of ValenciaUniversity of OuluRecruiting